Detalhe da pesquisa
1.
Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease.
Blood
; 139(2): 287-299, 2022 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534280
2.
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies.
Blood
; 135(15): 1287-1298, 2020 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32047896
3.
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
N Engl J Med
; 378(5): 439-448, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29385370
4.
Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria.
Blood
; 134(3): 304-316, 2019 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043425
5.
Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant Consortium.
Biol Blood Marrow Transplant
; 24(8): 1651-1656, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29753157
6.
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression.
Biol Blood Marrow Transplant
; 24(10): 2040-2046, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29933069
7.
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.
Blood
; 127(13): 1656-65, 2016 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26825712
8.
A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801.
Haematologica
; 103(11): 1915-1924, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29954931
9.
Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.
Biol Blood Marrow Transplant
; 23(10): 1669-1677, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28602958
10.
Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 21(7): 1273-7, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25865650
11.
Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.
Biol Blood Marrow Transplant
; 20(12): 1996-2003, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25196857
12.
Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.
Biol Blood Marrow Transplant
; 20(4): 549-55, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24440648
13.
Tabelecleucel for EBV+ PTLD following allogeneic HCT or SOT in a multicenter expanded access protocol.
Blood Adv
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38625984
14.
Immune markers of disease severity and treatment response in pediatric acquired aplastic anemia.
Pediatr Blood Cancer
; 60(3): 455-60, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22811079
15.
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy.
Transplant Cell Ther
; 29(7): 430-437, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37031746
16.
A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study.
Blood Adv
; 7(14): 3612-3623, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219586
17.
Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study.
Transplant Cell Ther
; 28(11): 771.e1-771.e10, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36044977
18.
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies.
J Clin Oncol
; 40(4): 356-368, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34855460
19.
Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.
Biol Blood Marrow Transplant
; 17(3): 341-50, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20685259
20.
Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission.
Biol Blood Marrow Transplant
; 17(12): 1833-40, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21683798